Dianthus Therapeutics Inc

DNTHNASDAQ · US

Holders

ACQUIREDT+30
Carr Edward
Dianthus Therapeutics Inc · NASDAQ
+20,000 sh · $357.6K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Carr Edward
Dianthus Therapeutics Inc · NASDAQ
−6,771 sh · $686.4K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Carr Edward
Dianthus Therapeutics Inc · NASDAQ
−3,501 sh · $358.5K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Carr Edward
Dianthus Therapeutics Inc · NASDAQ
−7,928 sh · $796.2K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Carr Edward
Dianthus Therapeutics Inc · NASDAQ
−700 sh · $73.1K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Carr Edward
Dianthus Therapeutics Inc · NASDAQ
−1,100 sh · $113.5K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDStale
Randhawa Simrat
Dianthus Therapeutics Inc · NASDAQ
−13,309 sh · $1.4M
Filed 3 Sept 2026SEC Form 4view source
ACQUIREDStale
Randhawa Simrat
Dianthus Therapeutics Inc · NASDAQ
+9,375 sh · $206.9K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Randhawa Simrat
Dianthus Therapeutics Inc · NASDAQ
−2,600 sh · $273.5K
Filed 3 Sept 2026SEC Form 4view source
REDUCEDStale
Randhawa Simrat
Dianthus Therapeutics Inc · NASDAQ
−7,215 sh · $766.6K
Filed 3 Sept 2026SEC Form 4view source